Quotient Sciences
Buying intent
39 tracked signals | Top 15 topics are below | Sales and Product are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Quotient Sciences's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
12d ago
16d ago
17d ago
17d ago
17d ago
20d ago
12d ago
12d ago
10d ago
17d ago
21d ago
16d ago
12d ago
21d ago
12d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Quotient Sciences
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileQuotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions,
Top accounts researching Quotient Sciences
names withheld on the public pageThese are companies whose own people brought up Quotient Sciences unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
151,426 companies · 839,012 people are researching Artificial Intelligence
Quotient Sciences's own team shows 7 signals on this topic. No one outside Quotient Sciences has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Drug Development1,331 cos · 4,701 people
- Clinical Trials4,086 cos · 17,225 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 2 people; Leadership — 1 person; Product — 1 person
What's been said
public posts by Quotient Sciences's teamNo public post naming Quotient Sciences has surfaced in the past year, so this is what Quotient Sciences's own team is posting about publicly — their topics, in their words.
Attending #CPHIAmericas ? Let's connect to discuss your program needs and explore how #QuotientSciences can support you through our #TranslationalPharmaceutics ® platform. This disruptive approach to drug development seamlessly integrates formulation development, #drugproduct manufacturing, and #clinical testing. Schedule a time to meet at the event today: https://bit.ly/4u9JhMk
May 2026